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Natural products are becoming an increasingly valuable resource in the design and 
development of new drug candidates. Since 2009 natural products have grossed over $16 billion 
(U.S. dollars) producing 10 out of the top 20 best-selling drugs on the market. Flinderoles, 
natural products isolated from the Flindersia plant found in Papua New Guinea, are garnering 
interest in the synthetic organic community due to their antimalarial properties, especially 
against chloroquine-resistant strains. Malaria is an infectious disease caused by the parasite 
Plasmodium falciparum which in 2010 led to 216 million cases worldwide, claiming 655,000 
victims. Based on previous research in synthesizing 1H-pyrrolo[1,2-a]indole frameworks via an 
indium catalyzed intramolecular Friedel-Crafts alkylation, we propose an efficient methodology 
for the synthesis of Flinderole C using a similar protocol. The compound will be synthesized in 
seven linear steps from tryptamine derivatives becoming shorter than previously reported 
synthesis (11 linear steps). If proven successful, this scheme will provide efficient alternatives to 
synthesizing large heteroaromatic-based natural products, aiding in the search for new drug 
candidates. 
Introduction 
A plethora of natural products serve as inspiration for many potent therapeutic and 
pharmaceutically relevant compounds. In the pharmaceutical industry, many discoveries of novel 
drugs and medical breakthrough have stemmed from the isolation of natural products. Assaying 
natural products is one of the most reliable strategies of drug discovery and development 
grossing over $16 billion (U.S. dollars) since 2009 and producing 10 of the top 20 best-selling 
drugs.
1
 Indole tryptamines, along with their analogs, are recognized as potent 5-HT receptor 
antagonists
2





In particular, the pyrrolo[1,2-a]indole and hydropyrido[1,2-a]indole 
frameworks have been recognized as key structural motifs in many anticancer, antimalarial, and 
psychoactive compounds. Mersicarpine and leuconoxine are hydropyrido[1,2-a]indoles that have 
cytotoxic effects against cancer while flinderole C and yuremamine are pyrrolo[1,2-a]indoles 
with antimalarial and psychoactive properties, respectively (Figure 1). 
Due to their large N-fused heteroaromatic cores, these molecules are difficult to 
synthesize, thereby emphasizing the need to find less harsh and high-yielding routes to produce 
these compounds. The heart of our research is focused on using a Lewis acid-catalyzed 
intramolecular Friedel-Crafts alkylation to offer a modular approach to the synthesis of complex 
natural products. To test our methodology we started by cyclizing substituted alkenes and 
cyclopropyl rings into 2,3-dihydro-1H-pyrrolo[1,2-a]indole and hydropyrido[1,2-a]indole cores, 
respectively (Figure 1). A plethora of electron donating and withdrawing bearing compounds 
were constructed and readily cyclized, establishing the versatility of our protocol.
4
 Our success 
with cyclizations of 3-methylindole warranted further exploration into using 2-methylindole to 
access the reactivity of the 7-position on the indole ring. By blocking the 2-position with a 
functional group, the Friedel-Crafts alkylation is forced to occur from the indole 7-position 




Figure 1. Natural products with pyridoindole and pyrroloquinoline cores 
generated the 6-5-6 membered scaffold from a wide scope of substituted alkenes. Success with 
intramolecular Friedel-Craft alkylations inspired our novel retrosynthetic approach to 
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synthesizing flinderole C. In this new route, the two halves of flinderole C will be synthesized 
separately and coupled together via a copper-promoted conjugate addition. Dethe reported a 
biomimetic synthesis affording 17% yield using 11 linear steps.
5
 The original synthesis by Toste 
et al. consisted of 4% yield over 18 total steps (longest linear sequence 14 steps).
6
 Our 
methodology will drastically reduce the number of reactions and become the shortest linear 
sequence published, seven steps. Success with this synthesis will demonstrate the versatility of 
acid-catalyzed diastereoselective intramolecular Friedel-Crafts alkylation to synthesize large, 
substituted heteroaromatic compounds and serve as an effective tool for the synthesis of other 
complex natural products. 
 
Synthesis of Hydropyrido[1,2-a]indole-6(7H)-ones 
(In collaboration with Dadasaheb Patil and Marchello Cavitt) 
 
The hydropyrido[1,2-a]indole framework, in particular its C(6)-oxidized congeners, 
occur in an impressive number of natural indole alkaloids and therapeutic compounds.
4
 Though 
the synthesis of these compounds is reported, many approaches require the use of harsh reaction 
conditions, toxic reactants, and inefficient multi-step mechanisms to synthesize N-fused 6-5-6 
heteroaromatic rings.
7
 By utilizing an electrocyclic ring closure via a Lewis acid-catalyzed 
intramolecular Friedel-Crafts alkylation of the indole core, we offer an efficient and modular 
approach to synthesizing hydropyrido[1,2-a]indole-6(7H)-ones from 3-methylindole; a relatively 
cheap, commercially available starting material. 
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Our new approach stems from our previous research with the Nazarov and homo-
Nazarov cyclizations. The Nazarov cyclization utilizes a Lewis/Brønsted acid to catalyze 
electrocyclic ring closure of a divinyl ketone to afford cyclopentanones.
8
 This concept has been 
further adapted into the homo-Nazarov cyclization which cyclizes vinyl-cyclopropyl ketones into 
cyclohexanones via a Lewis/Brønsted acid facilitated formation of an intermediate cyclic 
oxyallyl cation, followed by electrocyclic ring closure (Scheme 2).
9








Scheme 1. Nazarov and homo-Nazarov cyclizations
8,9
 
cyclization is well researched (over 500 publications), the homo-Nazarov mechanism is not (only 
five total publications) due to a lack of generality, poor yields (16-63%), and harsh reaction 
conditions.
9
 To solve these shortcomings, we envisioned using donor-acceptor cyclopropyl vinyl 
ketones bearing an α’-positioned ester (another secondary acceptor) to facilitate cyclization 
through localizing the charge density on the cyclic oxyallyl cation intermediate (Scheme 2).
9
 








alkenes and cyclopropanes with yields ranging from 30-93%.
9
 Our success with this 
methodology was an invaluable asset in our exploration of the synthesis of 3-substituted 
hydropyrido[1,2-a]indole-6(7H)-ones. 
 
By utilizing a similar protocol, we explored the scope and limitations of synthesizing 
hydropyrido[1,2-a]indole-6(7H)-ones from N-acylindole β-keto esters. Our approach involved 
Lewis-acid catalyzed cyclopropane ring-opening to generate a carbocation followed by an 
intramolecular Friedel-Crafts alkylation of the indole, proceeding through an aza-cationic 
intermediate, to generate the newly formed N-fused 6-membered ring (Scheme 3).
4






Scheme 3. Intramolecular cyclopropane ring opening/Friedel-Craft alkylation
1 
our study, we developed a modular preparation of the various cyclization precursors. Starting 
from 3-methylindole an N-acylation with commercially-available methyl malonyl chloride was 
conducted affording the 1,3-dicarbonyl scaffold (1). A diazo transfer using triethylamine and 
tosyl azide provided the α-diazoester (2). Cyclopropanation with Rh2(esp)2  






(bis[rhodium(α,α,α’,α’-tetramethyl-1,3-benzenedipropionic acid)]) in the presence of a requisite 
alkene constructs the desired methyl 1-(1 H-indole-carbonyl)-1-cyclopropanecarboxylate (3) 
with yields up to 70% over the three steps (Scheme 4).
4
 By changing the alkene during 
cyclopropanation, we were able to generate a wide variety of substrates with various electronic 
properties. 
 
 Figure 2. Substrate scope and yields of products4 
 
Starting with donor substituted cyclopropanes, cyclizations were assayed using indium 
triflate (our prescreened catalyst). As seen in Figure 2, the hydropyrido[1,2-a]indole products 
were generated for 2 and 4-methoxy phenyl cyclopropane in near quantitative yields (4a, 4b). 
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Next, electron withdrawing para-substituted phenyl, 4-fluorophenyl, 4-chlorophenyl, and 4-
nitrophenyl cyclopropanes were cyclized (4c, 4d, 4e, and 4f). Interestingly, room temperature 
cyclizations in DCM using 30 mol% In(OTf)3 yielded no reaction (only starting material), while 
reflux in 1,2-dichloroethane afforded cyclization with yields ranging from 50% to 52%; though 
only trace amounts of cyclized 4-nitrophenyl was generated as identified in 
1
H NMR spectrum of 
the crude product. A 2-furyl heteroaromatic donor group (4g) was also tested as the donor ligand 
resulting in 99% yield with a 4.5:1 diastereomeric ratio (trans:cis). Cyclopropanes of 4h and 4i 
(made from dihydropyran or dihydrofuran) were synthesized in yields of 97% and 93%, 





The functionality of additional cation stabilizing donor substituents on the cyclopropane 
was then tested by cyclization of phenyl-methyl and diethyl cyclopropanes to 4j and 4k with 
yields of 94% and 85%, respectively. We noticed the phenyl-methyl species was reacted at room 
temperature while the diethyl species required refluxing in 1,2-dichloroethane. Next 4l (derived 
from methylene cyclopentane) and 4m (derived from methylene cyclohexane) were cyclized in 
DCE with In(OTF)3 providing 88% and 79% yield, respectively. This is particularly notable 
since several hydropyrido[1,2-a]indole natural products have gem-dialkyl substituents at C(9) 




Cyclization of compounds bearing activating silyl substituents such as 4n (a t-
butyldiphenylsilyl group) afforded only one diastereomer with yields of 82%. This is important 
because the silyl group helps stabilize the carbocation (through β-silyl effect) and can be used for 
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further functionalization. Phthalimido and phenylthioether substituted cyclopropanes were also 
synthesized, producing 4o and 4p in 55 and 81% yields. The Cbz-protected ring-fused 




To further demonstrate the versatility of this methodology we explored the cyclization of 
4-methoxyphenyl cyclopropanes with various 3-substituted ligands. This was done to test the 
steric and electronic effects that various 3-substituents functionalities have on the Friedel-Crafts 
alkylation. Cyclization of 4r readily occurred at room temperature in 99% yield with 1.1:1 dr. 
Then phthalimide-protected tryptamine and 3-(2-bromoethyl)-1H-indole cyclopropanes were 
synthesized into 4s and 4t producing 78 and 99% yield, respectively. The phthalimide product 
can be readily deprotected using standard conditions to provide the free amine. With 4t, the 
bromine stayed intact through cyclization making it available for further functionalization. 





In summary, we provided an efficient and modular approach to constructing 
functionalized hydropyrido[1,2-a]indole-6(7H)-ones using an indium triflate facilitated catalytic 
ring-opening/Friedel-Crafts alkylation. The hydropyrido[1,2-a]indole products were synthesized 
in 4 linear steps with good to excellent yields (48%-99%), demonstrating the versatility of this 
methodology. Our success with this reaction sequence led to our investigation of construction 





Synthesis of Pyrrolo[3,2,1-ij]quinolines 
(In collaboration with Dadasaheb Patil and Marchello Cavitt) 
 
The pyrrolo[3,2,1-ij]quinoline core is a key fragment in many natural alkaloids and has 
shown bioactivity towards treatment of tuberculosis and cancer.
10
 Though the synthesis of these 
molecules is already reported, an effective modular approach has yet to present itself. With our 
previous success in constructing pyrrolo[1,2-a]indoles and hydropyrido[1,2-a]indoles, we 
envisioned that blocking the 2-position of the indole would result in a Friedel-Crafts alkylation at 
the 7-position on the other side of the ring. This should quickly generate the pyrrolo[3,2,1-
ij]quinoline structure in high yields, further substantiating the effectiveness of our methodology. 
We began our exploration by synthesizing a wide range of substrate precursors that could 
be further cyclized. By treating 2-methylindole with methyl malonyl chloride the β-ester-amide 
(5) was afforded. Next a Knovenagel condensation of the N-acylated indole and an 
aldehyde/ketone yielded the desired acrylate (6) (Scheme 5). With our substrates in hand we 
began to cyclize them to afford the corresponding pyrrolo[3,2,1-ij]quinoline (7) structure using 
the catalyst indium triflate. 
 




Starting with para-substituted phenyl substituents 4-methoxyphenyl, 4-nitrophenyl, and 
4-fluorophenyl were cyclized from their alkene substrates in 62.5%, 78%, and 94% yield (entries 
7a, 7b, and 7c). After establishing the effects of electron donating and withdrawing groups on 
cyclization, the effects of various indole 5-position, 3-position, and 2-position substituents were 
tested using the 4-methoxyphenyl substituted alkene as a standard (Figure 3). The addition of 
electron withdrawing groups such as fluorine and chlorine on the indole 5-position had no 
substantial effect, cyclizing to 88% and 90% yield, respectively (7d, 7e). Next, compound 7f was 
synthesized from 2,3-dimethylindole in 80% yield. This di-substituted system tests the effects of 
using additional stabilizing donor groups on the indole ring, showing that the addition indeed 
stabilizes the system increasing the yields from 62% to 80%. A heteroaromatic donating phenyl 
ligand was substituted at the 2-position cyclizing to 97% yield (7g). This was expected due to a 
pi-conjugated stabilizing effect contributed to the indole from the phenyl ring. Next, a 
cyclohexane attached to the indole 2 and 3 position cyclized to 82% yield and saturated 5 and 6 
carbon indole rings were cyclized with yields of 81% and 83%, respectively (7h, 7i, 7j). Lastly, a 
vinyl-phenyl substituted alkene was cyclized to 7k in 65% yield.  
Figure 3. Cyclized Aromatic Acrylates 
11 
 
In conclusion, this protocol produces the pyrrolo[3,2,1-ij]quinoline framework via an 
indium triflate catalyzed Friedel-Crafts alkylation of the indole. The pyrrolo[3,2,1-ij]quinoline 
products were synthesized in 3 linear steps with good-to-excellent yields (62% to 97%) 
establishing the effectiveness of this mechanism to produce several types of unique indole 
frameworks. With an efficient, well understood methodology we began to apply our protocol to 
the synthesis of natural products such as flinderole C. 
 
Synthesis of Flinderole C 
 
In an effort to discover new anti-malarial drugs capable of inhibiting the multi-drug 
resistant malarial strains, natural products such as flinderoles A-C, borreverine, isoborreverine, 
and dimethylisoborreverine are being assayed as potential treatments (Figure 4).  
 
Figure 4. Structural configuration of flinderoles A-C (8a, 8b, and 9), borreverine (10), isoborreverine (11a), and 
dimethylisoborreverine (11b) 
 
Flinderole A (8a) was discovered in the natural product library at the Eskitis Institute and 
isolated from the plant Flindersia acuminate.
11
 The natural products flinderoles B and C (8b, 9) 
12 
 
were isolated from HPLC bioassay-guided fractionation of Flindersia amboinensis extract and 
identified through product screening as potential anti-malarials.
11
 Borreverine (10), 
isoborreverine (11a), and dimethylisoborreverine (11b) were discovered before the flinderoles 
and are a unique set of tryptamine-isoprenes isolated from the plant Flindersia fournieri.
11
 When 
tested, the flinderoles and borreverine compounds showed inhibition of (chloroquine-resistant) P. 
falciparum growth with IC50 values ranging between 0.08 and 1.42 μM.
11
 Though these 
compounds are effective inhibitors, their limited availability in nature and difficulty in isolation 
requires the use of synthetic strategies to generate enough material for therapeutic drug activity 
studies.  
 
 The synthesis of flinderole C has been reported using two completely different schemes. 
In the protocol by Toste et al., the synthesis of flinderole C took 18 steps (14 longest linear 
sequence) in 4% overall yield.
6
 Their synthesis features a Horner-Wadsworth-Emmons 
olefination of a phosphate and ketone to join the two halves of the molecule together, followed 
by deprotection of t-butyldiphenylsilyl ether and some functional group manipulation to afford 
the N-dimethyl side chain. A retrosynthetic look at their protocol required the two pieces to be 
made separately before being fused together. A N-dimethyltryptamine piece would be 
constructed from a zinc-promoted Fisher indole reaction to create the protected 2-
methyltryptophol structure followed by an Arbuzov/Radical bromination to give rise to the 
desired phosphonate ester. The pyrrolidine scaffold was constructed more strategically starting 
with an N-alkylation of tryptophol to introduce a methyl ester, which subsequently underwent an 





 Though this was the first reported synthesis of flinderole C the scheme had several 
drawbacks including the use of strong bases and overall poor yields. 
  
 Later, Dethe et al. used a biomimetic pathway to synthesize Flinderole C in 17.2% 
overall yield using only 11 steps in the longest linear sequence.
5
 Their methodology hinged on 
the use of a monomeric tryptamine diene as a precursor in the synthesis. The scheme began with 
a treatment of N-protected indole aldehyde with Ph3P=CHCO2Et followed by an addition of 
MeMgBr to the generated ester, resulting in the creation of a 3-butene-2-ol tail on the indole.
5
 
This compound was the precursor to the N-unprotected and tryptamine diene compounds which 
were then cyclized using copper triflate. A treatment with 2-iodoxybenzoic acid followed by a 
reductive amination of the resulting bisaldehyde yielded flinderoles B and C in a 2 :3 ratio.
5
 This 
route had higher overall yields compared to the previous methodology but still consisted of a 
long reaction sequence that hinged on a low yielding cyclization.  
 
 Our modular approach was inspired from previous reports and our research with 
synthesizing pyrrolo[1,2-a]indoles. We envisioned using our Friedel-Craft alkylation 
methodology to shorten the synthesis of flinderole C and increase the diastereoselectivity of the  
products (Scheme 6). Our forward synthetic analysis of flinderole C starts with the acylation of 
an N,N-dimethyltryptamine (12) with a α-sulfonyl acetyl chloride followed by a Knovenagel 
condensation with 3-methyl-2-butenal to afford the requisite cyclization precursor (14). The 
divinyl amide (14) could then be cyclized using our modular Lewis acid-catalyzed 
intramolecular Friedel-Crafts alkylation to afford the pyrrolo[1,2-a]indole-3(2H)one (15). 
Triflate formation (16) followed by iron promoted methylation will generate the α,β-unsaturated  
14 
 
sulfone (17) which will then be coupled by copper-promoted conjugate addition. The conjugate 
addition will require 17 to be converted to a Grignard reagent before being treated with 18 in the 
presence of copper iodide. Finally a dissolving metal reduction will deprotect the phenyl sulfonyl 
groups yielding flinderole C (9). This approach will provide the flinderoles from commercially 
available tryptamine derivatives using a longest linear sequence of 7 steps.  
  
 Thus far, we have successfully synthesized the pyrrolo[1,2-a]indole-3(2H)one (22) and 
the N-sulfonyl acetamide (25). The construction of the pyrrolo piece took several trials before 
using the methodology shown below (Figure 5). Our attempts with acylating N,N-
dimethyltryptamine with the α-sulfonyl acetyl chloride lead to the loss of the dimethylamine 
while acylations with methyl malonyl chloride afforded extremely poor yields, requiring us to 
rethink our strategy. By using 3-(2-bromoethyl)-1H-indole, we envisioned an easier synthesis 
without the loss of functional groups during the subsequent reactions. Acylations with α-sulfonyl  
 
Scheme 6. Forward Synthetic Analysis of Flinderole C 
15 
 
acetyl chloride and 3-(2-bromoethyl)-1H-indole were conducted successfully, but the 
Knovenagel condensation with 3-methylbut-2-enal led to a deprotection of the phenyl sulfonyl 
group. By returning to our original methodology the 3-(2-bromoethyl)-1H-indole was readily 
converted into the β-keto ester (20) in 48 % yield, followed by a Knovenagel condensation with 
3-methylbut-2-enal to afford the desired acrylate (21) in 30 % yield. Though Friedel-Craft 
alkylation with In(OTf)3 afforded the pyrrolo[1,2-a]indole core (22), Sc(OTf)3 gave overall 
higher yields (66%) with fewer side products. 
 
The construction of the N-sulfonyl acetamide (24) also required revamping due to the 
loss of the functional groups during various stages of its synthesis. Starting with 2-(1H-indol-3-
yl)acetic acid, acylations with 4-methylbenzene-1-sulfonyl chloride afforded the N-protected 
indole acetic acid (23) in good yields, 57.8%. A formylation reaction was then conducted to yield  
Figure 5. Progress towards Synthesis of Flinderole C  
 
a 2-positioned aldehyde, but the chemistry failed most likely due to the reactivity of the 
carboxylic acid functionality. To bypass this discrepancy, treatment of the N-protected indole 
16 
 
acetic acid with oxalyl chloride, dimethyl amine, and catalytic amounts of DMF afforded the 
acetamide (24) which we hope will undergo formylation without any problems. Though the 
yields of these reactions are far from quantitative, further optimization using different solvents 
and reaction conditions should produce higher product ratios. An update on the synthesis of 




In summary, we report an efficient synthesis of hydropyrido[1,2-a]indole-6(7H)-ones and 
pyrrolo[3,2,1-ij]quinolines via an intramolecular In(OTf)3 catalyzed Friedel-Craft alkylation, 
demonstrating the versatility of our methodology. Further application of this protocol has been 
demonstrated in the synthesis of precursors used in the total synthesis of flinderole C. Our 
sequence is currently being applied to preparing mersicarpine and yuremamine, two natural 
products which are not well reported. By exploring modular approaches to constructing 
polycyclic compounds, we envision that our methodology will aid the preparation of N-fused 
heteroaromatic natural products. 
 




 All reactions were carried out in oven and flame-dried glassware. Each reaction was 
carried out under a nitrogen atmosphere using dry solvents, unless otherwise noted. The 
17 
 
tetrahydrofuran was distilled from sodium/benzophenone ketyl under nitrogen while the 
dichloromethane was purified by distillation from calcium hydride under nitrogen. All other 
reagents were purchased from Acros, Sigma-Aldrich, Fluka, VWR, Merck, Alfa Aesar, TCI or 
Strem (for metal catalysts).  
Purification was performed using flash chromatography with Silicycle silica gel (40-63 
μm) and technical grade solvents indicated as eluent with 0.1-0.5 bar pressure. Thin-layer 
chromatography (TLC) was performed on EMD silica gel 60 F254 TLC glass plates to gauge 
reaction completion and chromatographic separation. Visualization of TLC’s was accomplished 
via UV light, aqueous basic potassium permanganate (KMnO4) solution, and iodine chips. The 
yield of each reaction refers to isolated analytically pure material. 
 Infrared (IR) spectra were obtained using a Nicolet 4700 FTIR with an ATR attachment 
from SmartOrbit Thermoelectronic Corp. The IR bands are characterized as broad (br), weak 





C NMR) were recorded on a Varian Mercury Vx 300 spectrometer or a Varian 
Mercury Vx 400 spectrometer with solvent resonances as the internal standard (
1
H NMR: CDCl3 
at 7.26 ppm; 
13
C NMR: CDCl3 at 77.0 ppm). 
1
H NMR data are reported as follows: chemical 
shift (ppm), multiplicity (s = singlet, d = doublet, dd =doublet of doublets, dt = doublet of 
triplets, ddd = doublet of doublet of doublets, t = triplet, m = multiplet), coupling constants (Hz), 












A. N-Acylations of Indole Compounds 
 
Sodium hydride (1.1 equiv.) was suspended in THF (20 mL), cooled to 0 °C. A solution 
of the desired indole (1.0 equiv.) dissolved in 30 mL THF was syringed into the reaction vessel. 
After 30 min, methyl-3-chloro-3-oxopropanoate (1.1 equiv.) was slowly added to the solution 
and allowed to react for 14 h at room temperature. The reaction mixture was quenched with 
water (100 mL), the organic layer was separated, and the aqueous layer was extracted with 
EtOAc (3 x 100 mL).  The combined organic layers were washed with brine, dried with 
anhydrous sodium sulfate, filtered, and concentrated under reduced pressure.  The residue was 



































Methyl 3-(3-methyl-1H-indol-1-yl)-3-oxopropanoate (1a): A variation of the general 
procedure was followed using sodium hydride (1.90 g, 47.7 mmol), 3-methyl-1H-indole (5.00 g, 
38.1 mmol), methyl-3-chloro-3-oxopropanoate (4.9 mL, 45.7 mmol), and THF (50 mL). After  
14  h,  the  reaction  was  quenched, and column chromatography (20% EtOAc/Hex, Rf 0.26  and  
Rf  0.15  for  keto  and  enol  tautomers)  afforded 1a as a pale brown solid (6.44 g, 73%). [m.p. 
49-51°C] 
1
H NMR (300 MHz, CDCl3) δ 8.43 (d, J = 7.1 Hz, 
1
H), 7.52 – 7.47 (m, 1H), 7.41 – 
7.28 (m, 2H), 7.10 (s, 1H), 3.92 (s, 2H), 3.79 (s, 3H), 2.27 (s, J = 1.3 Hz, 3H). 
13
C NMR (75 
MHz, CDCl3) δ 166.8, 163.4, 136.0, 131.5, 125.5, 124.0, 121.4, 119.7, 118.9, 116.7, 52.9, 43.6, 
9.7. IR: 3051.9 (w), 2937.6 (w), 1747.0 (s), 1685.1 (s), 1604.1 (w), 1447.0 (s), 1375.5 (s), 
1232.6 (m), 1070.7 (m), 913.5 (m), 732.6 (s) cm
-1




























Methyl 3-(3-(2-methoxy-2-oxoethyl)-1H-indol-1-yl)-3-oxopropanoate (1u): The 
general procedure was followed using sodium hydride (0.702 g, 17.6 mmol), methyl 2-(1H-
indol-3-yl)acetate (3.00 g, 15.9 mmol), methyl-3-chloro-3-oxopropanoate (2.0 mL, 18.6 mmol), 
and THF (60 mL). After 16 h, the reaction was quenched, and column chromatography (30% 
EtOAc/Hex, Rf  0.24)  afforded 1u as  a  dark  brown oil  (3.55 g, 77%). 
1
H NMR (300 MHz, 
CDCl3) δ 8.43 (d, J = 8.0 Hz, 1H), 7.57 – 7.49 (m, 1H), 7.43 – 7.27 (m, 3H), 3.96 (s, 2H), 3.79 
(s, 3H), 3.73 (s, 2H), 3.72 (s, 3H). 
13
C NMR  (75  MHz,  CDCl3) δ  171.0,  166.6,  163.6, 135.8, 
130.1, 125.8, 124.2, 123.1, 118.9, 116.8, 116.0, 52.8, 52.2, 43.4, 30.6. IR: 3009.3 (w), 2952.1 
(w), 1737.4 (s), 1703.2 (s), 1595.1 (m), 1366.0 (s), 1265.7  (m),  1204.7  (s),  1148.4  (s),  1015.7  
(m),  909.4  (m), 728.3 (s) cm
-1






























Methyl 3-(3-(2-bromoethyl)-1H-indol-1-yl)-3-oxopropanate (20): A different method from 
the above methodology was utilized to synthesize this compound. A solution of 3-(2-
bromoethyl)-1H-indole (6.69 g, 29.8 mmol) and potassium carbonate (2.71 g, 19.6 mmol) was 
heated in acetonitrile until reflux (60 mL) before the addition of methyl malonyl chloride (5.67 
mL, 52.8 mmol). After allowing the reaction to stir all night the reaction was cooled, filtered, and 
dried in vacuo. The residue was extracted three times with EtOAc, separating the organic layer, 
dried with anhydrous magnesium sulfate, filtered, and concentrated in vacuo. Purification via 
column chromatography using 10% EtoAc/Hex yielding 20 as a light yellow oil (4.65 g, 48 
%).%). [m.p. 68-70°C] 
1
H NMR (300 MHz, CDCl3) δ 8.41 (d, J = 7.8 Hz, 1H), 7.47 (d, J = 7.6 
Hz, 1H), 7.40 – 7.24 (m, 2H),7.22 (s, 1H), 3.92 (s, 2H), 3.76 (s, 3H), 3.61 (t, J = 7.2 Hz, 2H), 
3.22 (t, J = 7.2 Hz, 2H). 
13
C NMR (75MHz, CDCl3) δ 166.5, 163.5, 135.7, 129.8, 125.6, 123.9, 
122.1, 120.4, 118.4, 116.7, 52.7, 43.3, 31.1,28.5. IR: 3091.7 (w), 2940.7 (w), 2878.8 (w), 1760.1 
(s), 1657.8 (s), 1615.6 (s), 1535.5 (s), 1440.9 (s), 1239.4 (s), 1191.4 (s), 1040.8 (m), 820.8 (m), 














Methyl 3-(2-methyl-1H-indol-1-yl)-3-oxopropanoate (5a): The general procedure was 
followed using sodium hydride (1.90 g, 47.7 mmol), 2-methyl-1H-indole (5.00 g, 38.1 mmol), 
methyl-3-chloro-3-oxopropanoate (4.9 mL, 45.7 mmol), and THF (125 mL). After 14 h, the 
reaction was quenched, and column chromatography (30% EtOAc/Hex, Rf 0.40) afforded 5a as a 
brick red solid (6.05 g, 68.7%). [m.p. 74 - 76°C]. 
1
H NMR (300 MHz, CDCl3) δ  ppm 7.93-7.87 
(m, 1H), 7.46-7.42 (m, 1H), 7.29-7.20 (m, 2H), 6.37 (t, J = 1.05 Hz, 1H), 4.05 (s, 2H), 3.81 (s, 
3H), 2.59 (d, J = 1.20 Hz, 3H). 
13
C NMR  (75  MHz,  CDCl3) δ 166.9, 165.8, 136.9, 136.3, 









Methyl 3-(2,3-dimethyl-1H-indol-1-yl)-3-oxopropanoate (5f): The general procedure was 
followed using sodium hydride (0.330 g, 8.26 mmol), 2,3-dimethyl-1H-indole (1.00 g, 6.88 
mmol), methyl-3-chloro-3-oxopropanoate (0.921 mL, 8.61 mmol), and THF (35 mL). After 14 h, 
the reaction was quenched, and column chromatography (20% EtOAc/Hex) afforded 5f as a pale 
yellow solid (1.05 g, 62.2%). [m.p. 75-77°C]. 1H NMR (300 MHz, CDCl3) δ  ppm 7.77-7.84 (m, 
1H), 7.26-7.32 (m, 1H), 7.17 (m, 2H), 3.88 (s, 2H), 3.72 (s, 3H), 2.34 (s, 3H), 2.03 (s, 3H).
 13
C 
NMR  (75  MHz,  CDCl3) δ ppm 8.1, 13.4, 45.1, 52.1, 114.4, 115.7, 117.7, 122.8, 123.5, 130.7, 






B. Formation of Diazo Compounds 
 
The β-amide ester (1.0 equiv.) was dissolved in acetonitrile and treated with triethylamine 
(1.2 equiv.). After stirring for 10 min, tosyl azide (1.2 equiv.) was placed in the reaction flask. 
The mixture was stirred at room temperature for 12 h and concentrated under reduced pressure. 









Methyl 2-diazo-3-(3-methyl-1H-indol-1-yl)-3-oxopropanoate (2a): The general 
procedure was followed using methyl 3-(3-methyl-1H-indol-1-yl)-3-oxopropanoate (2.71 g, 11.7 
mmol), triethylamine (2.0 mL, 14.4 mmol), tosyl azide (2.81 g. 14.2 mmol), and acetonitrile (30 
mL). After 12 h, the reaction mixture was concentrated, and column chromatography (20% 
EtOAc/Hex, Rf 0.41) afforded 2a as a yellow solid (2.79 g, 93%). [m.p. 74-76°C] 
1
H NMR (300 
MHz, CDCl3) δ 8.17 (d, J = 8.6 Hz, 1H), 7.51 – 7.47 (m, 1H), 7.39 –7.26 (m, 2H), 7.11 (s, 1H), 
3.85 (s, 3H), 2.28 (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 161.5, 158.9, 136.0, 131.7, 124.8, 
123.7, 123.3, 118.9, 117.7, 115.7, 69.7, 52.6, 9.7. IR: 3047.1 (w), 2956.6 (w), 2918.5 (w), 
2132.7 (s), 1708.9 (s), 1651.7 (s), 1601.0 (m), 1466.0 (s), 1349.6 (s), 1302.9 (s), 1254.3(s), 












Methyl  2-diazo-3-(3-(2-methoxy-2-oxoethyl)-1H-indol-1-yl)-3-oxopropanoate (2u):  
The general procedure was followed using methyl 3-(3-(2-methoxy-2-oxoethyl)-1H-indol-1-yl)-
3-oxopropanoate (1.49 g, 5.16 mmol), triethylamine (880 µL, 6.31 mmol), tosyl azide (1.22 g, 
6.19 mmol), and acetonitrile (20 mL).  After 18 h, the reaction mixture was concentrated, and 
column chromatography (40% EtOAc/Hex, Rf 0.43) afforded 2u as a brown solid (1.36 g, 83%). 
[m.p. 77-79°C] 
1
H NMR (300 MHz, CDCl3) δ 8.17 (d, J = 7.8 Hz, 1H), 7.52 (d, J = 7.7 Hz, 1H), 
7.41 – 7.26 (m, 3H), 3.84 (s, 3H), 3.73 (s, 2H), 3.72 (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 
171.1, 161.3, 159.2, 135.9, 130.3, 125.2, 125.1, 123.9, 118.9, 115.8, 114.1, 70.1, 52.7, 52.1, 30.7. 
IR: 2999.5 (w), 2961.4 (w), 2137.5 (s), 1721.8 (s), 1637.44 (s), 1599.3 (w), 1446.9 (s), 1364.2 
(s), 1305.1 (s), 1253.8 (s), 1139.6 (s), 1051.6 (w), 870.7 (m), 747.9 (s) cm-1. HRMS (ESI) M/Z 




















C. Synthesis of the Cyclopropanes 
 
A round bottom flask was charged with Rh2(esp)2 (0.1 mol%) and 2.0 mL DCM was 
added to the flask. The reaction vessel was cooled to 0°C, and the corresponding alkene (1.0 
equiv.) was added. After 10 min, the diazo reagent (1.3 equiv.) was dissolved in DCM (5 mL) 
and syringed into the reaction mixture. After 10 min, the ice bath was removed and the reaction 
proceeded at room temperature. Upon completion (monitored by TLC) or 12 h of reactivity, the 
solution was quenched with saturated thiourea and stirred for 30 min. The organic layer was 
separated, and the aqueous layer extracted three times with DCM. The combined organic layers 
were washed with brine, dried with anhydrous sodium sulfate, filtered, and concentrated under 









Methyl 2-(4-methoxyphenyl)-1-(3-methyl-1H-indole-1-carbonyl) cyclopropane carboxylate 
(3a): The general procedure was followed using 4-methoxystyrene (0.201 g, 1.49 mmol), methyl 
2-diazo-3-(3-methyl-1H-indol-1-yl)-3-oxopropanoate (0.500 g, 1.94 mmol), Rh2(esp)2  (1.5 mg, 
1.98 μmol) and DCM (8 mL). After 12 h, the reaction was quenched, and column 
chromatography (20% EtOAc/Hex, Rf 0.52) afforded 3a as a pale yellow solid (0.328 g, 60%). 
[m.p. 110-112°C] 
1
H NMR (300 MHz, CDCl3) δ 8.45 (d, J = 8.0 Hz, 1H), 7.61-7.45 (m, 1H), 
7.44 – 7.26 (m, 5H), 6.90 – 6.83 (m, 2H), 3.81 (s, 3H), 3.41 (t, J = 4Hz, 1H), 3.41 (s, 3H), 2.40 
(dd, J = 8.3, 5.2 Hz, 1H), 2.28 (s, 3H), 1.82 (dd, J = 9.3, 5.2 Hz, 1H). 
13
CNMR (75 MHz, 
CDCl3) δ 168.0, 165.8, 158.9, 136.0, 131.5, 130.2, 126.1, 125.4, 123.8, 121.5, 119.2, 118.9, 
26 
 
116.5, 113.6, 55.2, 52.8, 39.5, 31.1, 18.8, 9.8. IR: 3050.0 (w), 2914.3 (m), 1742.9 (m), 1681.0 
(s), 1600.0 (m), 1514.29 (m), 1450.0 (s), 1346.3 (s), 1246.8 (s), 1176.5 (s), 1028.6 (s), 838.1 (s), 
748.2 (s) cm
-1












cyclopropanecarboxylate  (3u): The general procedure was followed using 4-methoxystyrene  
(0.211 g, 1.57 mmol), methyl 2-diazo-3-(3-(2-methoxy-2-oxoethyl)-1H-indol-1-yl)-3-
oxopropanoate (0.611  g, 1.94 mmol,), Rh2(esp)2   (1.5  mg, 1.98 µmol), and DCM (8 mL). After 
14 h, the reaction was quenched, and column chromatography (20% EtOAc/Hex, Rf 0.21) 
afforded 3u as a yellow solid (0.312 g, 47%). [m.p. 82 – 84°C]. 
1
H NMR (300 MHz, CDCl3) δ 
8.46 (d, J = 8.1 Hz, 1H), 7.58 – 7.49 (m, 2H), 7.46 – 7.26 (m, 4H), 6.92 – 6.82 (m, 2H), 3.81 (s, 
3H), 3.73 (s, 2H), 3.73 (s, 3H), 3.43 (s, 3H), 3.43 (t, J = 4.5 Hz, 1H), 2.42 (dd, J = 8.3, 5.3 Hz, 
1H), 1.86 (dd, J  =  9.4,  5.2 Hz,  1H). 
13
C NMR (75 MHz, CDCl3) δ 171.0, 167.8, 166.0, 158.9, 
135.9, 130.2, 130.1, 125.9, 125.6, 124.0, 123.3, 119.0, 116.6, 115.7, 113.6, 55.2, 52.8, 52.2, 39.3, 
31.3, 30.8, 18.9.  IR: 3009.0 (w), 2947.1 (w), 1742.2 (s), 1694.6 (s), 1608.9 (m), 1504.1 (m), 
1446.9 (s), 1356.5 (s), 1246.9 (s), 1032.6 (m), 827.8 (m), 732.8 (s) cm
-1
. HRMS (ESI) M/Z 







D. Knovenagel Condensation of β-Keto Ester 
 
In a dry flask the requisite aldehyde (1.3 equiv.), piperidine (0.1 equiv.), and acetic acid 
(0.4 equiv.) were added to 25 mL of benzene. The solution was then brought to reflux using a 
Dean-Stark apparatus and allowed to react for 12 hours. The solution was then quenched using 
water and extracted using ethyl acetate. The organic layer was then washed with 1N HCl and 
sodium bicarbonate before being dried with magnesium sulfate and concentrated under vacuum. 
The residue was separated and purified via silica gel flash chromatography. 











 (2Z,4E)-Methyl 2-(2-methyl-1H-indole-1-carbonyl)-5-phenylpenta-2,4-dienoate (6k): The 
general procedure was followed using methyl 3-(2-methyl-1H-indol-1-yl)-3-oxopropanoate 
(0.300 g, 1.29 mmol), cinnamaldehyde (0.21 mL, 1.69 mmol), piperidine (13.9 μL, 0.129 mmol), 
and acetic acid (0.0357 g, 0.596 mmol) in 25 mL of benzene. After 20 h, the reaction was 
quenched and column chromatography (20% EtOAc/Hex) afforded 6k as a reddish orande oil 
(0.256 g, 57.2 %). 
1
H NMR (300 MHz, CDCl3) δ ppm 7.78 (s, 1H), 7.43 (m, 4H), 7.29 (m, 5H), 
7.15 (s, 1H), 6.88 (dd, J = 15.35, 11.74 Hz, 1H), 6.42 (s, 1H), 3.74 (s, 3H), 2.54 (d, J = 1.09 Hz, 
3H). ).
 13
C NMR (75 MHz, CDCl3) δ 165.1, 164.8, 145.4, 145.0, 136.7, 136.6, 135.1, 130.0, 
129.7, 129.7, 129.0, 128.8, 128.5, 127.8, 123.9, 123.7, 122.2, 119.8, 115.3, 110.4, 52.6, 16.7. dr 










(Z)-methyl 2-(2,3-dimethyl-1H-indole-1-carbonyl)-3-(4-methoxyphenyl)acrylate (6f): The 
general procedure was followed using methyl 3-(2,3-dimethyl-1H-indol-1-yl)-3-oxopropanoate 
(1.00 g, 4.08 mmol), 4-methoxybenzaldehyde (0.617 mL, 5.09 mmol), piperidine (0.040 mL, 
0.407 mmol), and acetic acid (0.112 g, 1.88 mmol) in 60 mL of benzene. After 18 h, the reaction 
was quenched and column chromatography (20% EtOAc/Hex) afforded 6f as a yellow solid 
(1.08 g, 72.9 %). [m.p. 94-96°C]. 
1
H NMR (300 MHz, CDCl3) δ 8.63 (br. s, 1H), 7.87 (br. s., 
1H), 7.33 - 7.48 (m, 3H), 7.28 (br. s., 2H), 6.73 (d, J = 8.50 Hz, 2H), 3.77 (s, 3H), 3.67 (d, J = 
1.21 Hz, 3H), 2.25 - 2.53 (m, 3H), 2.15 (s, 3H).
 13
C NMR (75 MHz, CDCl3) δ 165.9, 165.2, 
161.9, 142.5, 136.1, 131.8, 131.5, 126.6, 125.3, 124.3, 123.6, 117.9, 116.5, 114.6, 55.2, 52.4, 





























(Z)-methyl 2-(3-(2-bromoethyl)-1H-indole-1-carbonyl)-5-methylhexa-2,4-dienoate (21): The 
general procedure was followed using methyl 3-(3-(2-bromoethyl)-1H-indol-1-yl)-3-
oxopropanate (1.25 g, 3.86 mmol), 3-methyl-2-butenal (0.421 g, 5.01 mmol), piperidine (32.8 
mg, 0.386 mmol), and acetic acid (0.106 g, 1.77 mmol) in benzene (25 mL). After 12 hours the 
reaction was quenched and column chromatography (20 % EtOAc/Hex) yielding 21 as a dark red 
solid (0.411 g, 27.4 %).
1
H NMR (300 MHz, CDCl3) δ ppm 8.62 (s, 1H), 7.89 (d, J = 12.45 Hz, 
1H), 7.56-7.30 (m, 3H), 7.06 (s, 1H), 5.96 (dd, J = 12.48, 1.14 Hz, 1H), 3.75 (s, 3H), 3.62 (t, J = 
7.33, 7.33 Hz, 2H), 3.18 (td, J = 29.00, 7.18, 7.18 Hz, 2H), 1.99 (s, 3H), 1.83 (s, 3H).
 13
C NMR 
(75 MHz, CDCl3) δ 164.8, 153.2, 140.4, 135.4, 130.5, 133.2, 125.4, 124.0, 120.2, 119.1, 118.4, 













E. In(OTf)3 Catalyzed Friedel-Craft Alkylations 
 
Cyclopropyl β-amide ester (1.0 equiv) was added to a solution of In(OTf)3 (0.30 
equiv) in anhydrous dichloromethane (2 mL) at room temperature. Upon completion, the 
reaction mixture was quenched with water and the product was extracted from the aqueous phase 
with dichloromethane. The combined organic layers were washed with brine and dried over 
MgSO4. The organic layers were concentrated for silica gel flash column chromatography. 
General Method B: To a mixture of In(OTf)3 (0.30 equiv) in anhydrous 1,2-dichloroethane 
heated to a reflux, dissolved cyclopropyl β-amide ester (1.0 equiv) was syringed into the reaction 
vessel. The reaction was monitored by TLC and quenched with water. The phases were 
separated, and the product was extracted from the aqueous phase with dichloromethane. The 
combined organic layers were washed with brine, dried over MgSO4, filtered, and concentrated 

























Carboxylate (4a): Methyl 2-(4-methoxyphenyl)-1-(3-methyl-1H-indole-1-
carbonyl)cyclopropanecarboxylate (0.100 g, 0.275 mmol), In(OTf)3 (0.046 g, 0.082 mmol) and 
DCM (4 mL) were combined according to general method A to afford 4a as a pale brown oil 
(0.099 g, 99%) after 2 h. Rf 0.35 (20% EtOAc/Hex). dr. (2.6:1). 
1
H NMR (300 MHz, CDCl3) δ 
8.55 – 8.47 (m, 1.34), 7.50 – 7.28 (m, 4.53), 7.15 – 7.09 (m, 0.86), 7.01 – 6.95 (m, 2.09), 6.88 – 
6.80 (m, 3.05), 4.59 (t, J = 4.3 Hz, 0.94), 4.34 (dd, J = 8.5, 5.1 Hz, 0.36), 3.81 – 3.78 (m, 8.28), 
3.69 (d, J = 4.5 Hz, 0.56), 3.65 (d, J = 4.5 Hz, 0.56), 3.56 (d, J = 1.1 Hz, 1.37), 2.92 – 2.68 (m, 
1.40), 2.59 – 2.34 (m, 1.39), 2.00 (s, 3.0), 1.75 (s, 1.26). 
13
C NMR (75 MHz, CDCl3) δ 169.6, 
169.2, 165.0, 164.9, 158.5, 158.5, 134.5, 134.4, 133.7, 133.5, 132.8, 132.3, 131.3, 131.0, 128.9, 
128.3, 124.8, 124.8, 124.1, 124.0, 118.1, 118.0, 116.5, 115.2, 114.8, 114.1, 113.9, 55.1, 52.5, 
52.4, 49.7, 47.1, 43.4, 37.9, 35.2, 33.8, 33.0, 8.7, 8.3. IR: 3051.9 (w), 2932.8 (w), 1747.0 (s), 
1685.1 (s), 1618.4 9 (w), 1451.7 (s), 1366.0 (s), 1242.2 (s), 1170.7 (s), 1156.4 (s), 1023.1 (s), 
899.2 (m), 729.0 (s) cm
-1




















tetrahydropyrido[1,2-a]indole-7-carboxylate (4u): Methyl  1-(3-(2-methoxy-2-oxoethyl)-1H-
indole-1-carbonyl)-2-(4-methoxyphenyl) cyclopropanecarboxylate (0.070  g,  0.167  mmol), 
In(OTf)3  (0.028  g,  0.049  mmol) and DCM (3 mL) were  combined  according  to general 
method A  to  afford 4u  as a brown oil (0.062 g, 88.0%) after 3 h. Rf  0.45  (40%  EtOAc/Hex). 
iastereomeric ratio: (2.0:1). 
1
H NMR  (300  MHz,  CDCl3) δ 8.56 – 8.47 (m, 1.45), 7.56 – 7.48  
(m, 1.05), 7.44 – 7.28  (m, 3.67), 7.18 – 7.11  (m, 1.06), 7.01 – 6.90  (m, 2.29), 6.88 – 6.78 (m, 
3.02), 4.66 (t, J = 4.5 Hz, 1), 4.40 (dd, J = 9.7, 5.1 Hz, 0.48), 3.90 – 3.81 (m, 1.32), 3.81 – 3.78 
(m, 7.54), 3.73 – 3.67 (m, 1.32), 3.64 (s, 1.44), 3.55 (s, 1.42), 3.53 (s, 2.98), 3.52 (s, 0.31), 3.43 
(d, J = 17.3 Hz, 1.59), 3.32 (d, J  =  17.7  Hz,  0.85), 3.02 –  2.69 (m, 2.34), 2.58 –  2.38  (m,  
1.62). 
13
C NMR  (75 MHz, CDCl3) δ 170.8, 170.6, 169.4, 169.1, 165.2, 158.9, 158.8, 136.3, 
135.8, 134.6, 134.5, 132.3, 131.9, 130.3, 129.9, 129.2, 128.5, 125.2, 125.2, 124.5, 124.4, 118.4, 
118.0, 116.7, 114.2, 114.1, 112.3, 112.0, 55.3, 52.7, 52.6, 52.0, 51.9, 50.1, 47.2, 38.5, 35.4, 34.0, 
33.2, 29.7, 29.4.  IR:  3013.8 (w),  2918.6  (w), 2832.8 (w), 1747.0 (s), 1737.7 (s), 1699.3 (s), 
1613.6 (m), 1518.4 (m), 1456.5 (s), 1366.0 (s), 1245.6 (s), 1152.1 (s), 1032.6 (s), 837.3 (m), 
731.8 (s) cm
-1















carboxylate (7k): (2Z, 4E)-methyl 2-(2-methyl-1H-indole-1-carbonyl)-5-phenylpenta-2,4-
dienoate (0.0700 g, 0.2028 mmol), In(OTf)3 (0.0341 g, 0.0608 mmol) and toluene (4 mL) were 
combined according to the  general procedure to afford 7k as a pale yellow solid (0.0457 g, 
65.32%) after 14 h. (20% EtOAc/Hex, Rf 0.35). [m.p. 98 - 100 °C].
 1
H NMR  (300  MHz,  
CDCl3)  7.15 - 7.44 (m, 7H), 7.08 (d, J = 7.40 Hz, 1H), 6.63 (d, J = 15.68 Hz, 1H), 6.40 (d, J = 
1.14 Hz, 1H), 6.24 (dd, J = 8.65, 15.68 Hz, 1H), 4.58 (t, J = 9.44 Hz, 1H), 4.00 (d, J = 10.22 Hz, 
1H), 3.78 (s, 3H), 2.64 - 2.74 (m, 3H). 
13
C NMR  (75 MHz, CDCl3)  169.0, 164.0, 137.2, 136.2, 
134.6, 134.5, 128.6, 128.0, 127.6, 126.5, 126.4, 124.1, 121.0, 120.5, 118.8, 109.3, 56.7, 52.8, 




















5-carboxylate (7f): (Z)-Methyl 2-(2,3-dimethyl-1H-indole-1-carbonyl)-3-(4-
methoxyphenyl)acrylate (0.0900 g, 0.2476 mmol), In(OTf)3 (0.0208 g, 0.0371 mmol) and DCE 
(5 mL) were combined according to the  general procedure to afford 7f as a colorless oil (0.774 
g, 86.0%) after 4 h. (20% EtOAc/Hex, Rf 0.40). 
1
H NMR  (300  MHz,  CDCl3)  7.45 (d, J = 
7.73 Hz, 1H), 7.40 (s, 1H), 7.27 - 7.33 (m, 2H), 6.98 - 7.04 (m, 2H), 6.86 (d, J = 7.44 Hz, 1H), 
5.08 (d, J = 10.66 Hz, 1H), 4.31 (d, J = 10.66 Hz, 1H), 3.93 - 3.97 (m, 3H), 3.82 (s, 3H), 2.78 (s, 
3H), 2.35 (s, 3H). 
13
C NMR  (75 MHz, CDCl3)  169.2, 163.6, 159.0, 134.0, 132.3, 131.2, 129.5, 
129.0, 123.8, 122.5, 121.1, 116.9, 116.6, 114.3, 58.9, 55.2, 52.6, 45.2, 12.4, 8.6. HRMS (ESI) 























a]indole-2-carboxylate (22): A varying synthesis route was used compared to the above general 
methodology. A solution of Sc(OTf)3 (15 mol %) was refluxed in xylene before (Z)-methyl 2-(3-
(2-bromoethyl)-1H-indole-1-carbonyl)-5-methylhexa-2,4-dienoate (500 mg, 1.21 mmol ) was 
added to the solution. After two hours, the reaction was quenched with water, extracted with 
EtoAC, the organic layer was dried with magnesium sulfate, filtered, and concentrated in vacuo 
for column chromatography. The residue was columned (20% EtoAc/Hex) affording 22 as a dark 
red solid (0.311 g, 66 %). 
1
H NMR  (300  MHz,  CDCl3)  ppm 8.01 (ddd, J = 6.15, 3.25, 0.74 
Hz, 1H), 7.44 (dd, J = 5.76, 3.29 Hz, 1H), 7.29 (dd, J = 5.91, 3.20 Hz, 2H), 5.20 (d, J = 10.26 
Hz, 1H), 4.74 (dd, J = 9.90, 5.29 Hz, 1H), 3.84 (s, 3H), 3.80 (d, J = 5.28 Hz, 1H), 3.70-3.63 (m, 
1H), 3.52 (dt, J = 7.63, 7.30, 1.24 Hz, 1H), 3.09 (td, J = 30.75, 7.21, 7.21 Hz, 2H), 1.84 (dd, J = 
3.50, 1.32 Hz, 3H), 1.80 (t, J = 1.54, 1.54 Hz, 3H). 
13
C NMR  (75 MHz, CDCl3)  168.1, 165.1, 





















2-(1-tosyl-1H-indol-3-yl)acetic acid (23): A solution of 2-(1H-indol-3-yl)acetic acid (5.25 g, 
30.0 mmol) was cooled to -78°C and allowed to react with n-BuLi (4.10 g, 64.0 mmol) for one 
hour. Then a solution of ClSO2PhMe (7.41 g, 39 mmol) in THF (50 mL) was slowly added to the 
solution, warmed to room temperature, and allowed to react overnight. The reaction was 
concentrated in vacuo, dissolved in DCM, washed with brine then 1 N HCL, and the organic 
layer was concentrated for chromatography. The residue was purified using column 
chromatography (20% EtoAc/Hex) affording 5.71g of 23 as a brown solid in 57.8% yield. 
1
H 
NMR  (300  MHz,  CDCl3)  ppm 11.78 (s, 1H), 8.01 (d, J = 7.81 Hz, 1H), 7.77 (d, J = 8.36 Hz, 
2H), 7.62 (s, 1H), 7.50 (d, J = 7.88 Hz, 1H), 7.34 (m, 4H), 3.74 (s, 2H), 2.28 (s, 3H). 
13
C NMR  
(75 MHz, CDCl3)  176.9, 144.9, 134.9, 134.8, 130.1, 129.8, 126.7, 124.8, 123.2, 119.4, 114.1, 



















N,N-dimethyl-2-(1-tosyl-1H-indol-3-yl)acetamide (24): 2-(1-tosyl-1H-indol-3-yl) acetic acid 
(500 mg, 1.51 mmol) was dissolved in dry DCM (12 mL) and cooled to 0°C before the addition 
of oxalyl chloride (250 mg, 1.97 mmol) and catalytic amounts of DMF (0.1 mL). The solution 
was allowed to react for 3 hours before being concentrated in vacuo, dissolving in dry THF (12 
mL), and adding 40% dimethylamine in water (255 mg, 2.26 mmol).  The reaction was extracted 
with EtOAc, washed with brine, and the organic layer was concentrated in vacuo. Using column 
chromatography (70% EtOAc/Hex) separated 24 as a brown oil yielding 0.210 g (69.1 %). 
1
H 
NMR  (300  MHz,  CDCl3)   ppm 7.95 (d, J = 8.97 Hz, 1H), 7.72 (d, J = 7.94 Hz, 2H), 7.51 (d, 
8.50 Hz 1H), 7.49 (s, 1H), 7.22 (m, 4H), 3.69 (s, 2H), 2.95 (dd, J = 7.79, 0.93 Hz, 6H), 2.26 (s, 
3H). 
13
C NMR  (75 MHz, CDCl3) 169.6, 144.7, 134.8, 130.4, 129.6, 126.6, 124.7, 123.9, 
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